Log In
BCIQ
Print this Print this
 

GN-4474

  Manage Alerts
Collapse Summary General Information
Company Atterx Biotherapeutics Inc.
DescriptionRecombinant bacterium that is able to conjugate with and kill Gram-negative bacteria
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard IndicationGram-negative bacterial infection
Indication DetailsTreat Gram-negative bacterial infections
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today